These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 11310618)

  • 1. N-acetyl aspartate--a neuronal marker?
    Barker PB
    Ann Neurol; 2001 Apr; 49(4):423-4. PubMed ID: 11310618
    [No Abstract]   [Full Text] [Related]  

  • 2. [Proton magnetic resonance spectroscopy in the evaluation of cognitive disturbances].
    Mathiesen HK; Nielsen AS; Nielsen K; Hanson LG
    Ugeskr Laeger; 2006 Jan; 168(4):357-9. PubMed ID: 16436234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absence of N-acetylaspartate in the human brain: impact on neurospectroscopy?
    Martin E; Capone A; Schneider J; Hennig J; Thiel T
    Ann Neurol; 2001 Apr; 49(4):518-21. PubMed ID: 11310630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White matter proton MR spectroscopy in children with isolated developmental delay: does it mean delayed myelination?
    Fayed N; Morales H; Modrego PJ; Muñoz-Mingarro J
    Acad Radiol; 2006 Feb; 13(2):229-35. PubMed ID: 16428059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRS and fMRI in partial epilepsies.
    Cendes F
    Arq Neuropsiquiatr; 2003 Sep; 61 Suppl 1():78-82. PubMed ID: 15104395
    [No Abstract]   [Full Text] [Related]  

  • 6. [Magnetic resonance spectroscopy in the central nervous system].
    Reith W
    Radiologe; 2010 Sep; 50(9):765-6. PubMed ID: 20924740
    [No Abstract]   [Full Text] [Related]  

  • 7. 1H-magnetic resonance spectroscopy markers of cognitive and language ability in clinical subtypes of autism spectrum disorders.
    Gabis L; Wei Huang ; Azizian A; DeVincent C; Tudorica A; Kesner-Baruch Y; Roche P; Pomeroy J
    J Child Neurol; 2008 Jul; 23(7):766-74. PubMed ID: 18487520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-vivo proton MR-spectroscopy of the human brain: assessment of N-acetylaspartate (NAA) reduction as a marker for neurodegeneration.
    Block W; Träber F; Flacke S; Jessen F; Pohl C; Schild H
    Amino Acids; 2002; 23(1-3):317-23. PubMed ID: 12373553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lithium citrate for Canavan disease.
    Janson CG; Assadi M; Francis J; Bilaniuk L; Shera D; Leone P
    Pediatr Neurol; 2005 Oct; 33(4):235-43. PubMed ID: 16194720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of human immunodeficiency virus induced inflammation and oxidative stress in lenticular nuclei with magnetic resonance spectroscopy despite antiretroviral therapy.
    Roc AC; Ances BM; Chawla S; Korczykowski M; Wolf RL; Kolson DL; Detre JA; Poptani H
    Arch Neurol; 2007 Sep; 64(9):1249-57. PubMed ID: 17620480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of the N-acetylaspartate multiplet in the quantification of brain metabolites.
    Thompson RB; Allen PS
    Biochem Cell Biol; 1998; 76(2-3):497-502. PubMed ID: 9923719
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton magnetic resonance spectroscopy of the hippocampus in patients with mild cognitive impairment: a pilot study.
    Franczak M; Prost RW; Antuono PG; Mark LP; Jones JL; Ulmer JL
    J Comput Assist Tomogr; 2007; 31(5):666-70. PubMed ID: 17895774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between N-acetyl-aspartate in gray and white matter of abstinent methamphetamine abusers and their history of drug abuse: a proton magnetic resonance spectroscopy study.
    Sung YH; Cho SC; Hwang J; Kim SJ; Kim H; Bae S; Kim N; Chang KH; Daniels M; Renshaw PF; Lyoo IK
    Drug Alcohol Depend; 2007 Apr; 88(1):28-35. PubMed ID: 17084995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study.
    Appenzeller S; Li LM; Costallat LT; Cendes F
    Brain; 2005 Dec; 128(Pt 12):2933-40. PubMed ID: 16195241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of neurometabolites in subacute sclerosing panencephalitis by 1H-MRS.
    Aydin K; Tatli B; Ozkan M; Ciftci K; Unal Z; Sani S; Ozmen M; Caliskan M; Aydinli N; Guven S
    Neurology; 2006 Sep; 67(5):911-3. PubMed ID: 16966569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Contribution of magnetic resonance spectrometry to the diagnosis of intracranial tumors].
    Galanaud D; Nicoli F; Le Fur Y; Roche P; Confort-Gouny S; Dufour H; Ranjeva JP; Peragut JC; Viout P; Cozzone PJ
    Ann Med Interne (Paris); 2002 Dec; 153(8):491-8. PubMed ID: 12610422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Contribution of magnetic resonance spectroscopy in predicting severity and outcome in traumatic brain injury].
    Payen JF; Francony G; Fauvage B; Le Bas JF
    Ann Fr Anesth Reanim; 2005 May; 24(5):522-7. PubMed ID: 15904731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions.
    Möller-Hartmann W; Herminghaus S; Krings T; Marquardt G; Lanfermann H; Pilatus U; Zanella FE
    Neuroradiology; 2002 May; 44(5):371-81. PubMed ID: 12012120
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissociating anxiety from pain: mapping the neuronal marker N-acetyl aspartate to perception distinguishes closely interrelated characteristics of chronic pain.
    Grachev ID; Fredickson BE; Apkarian AV
    Mol Psychiatry; 2001 May; 6(3):256-8. PubMed ID: 11326290
    [No Abstract]   [Full Text] [Related]  

  • 20. Proton magnetic resonance spectroscopy in ecstasy (MDMA) users.
    Daumann J; Fischermann T; Pilatus U; Thron A; Moeller-Hartmann W; Gouzoulis-Mayfrank E
    Neurosci Lett; 2004 May; 362(2):113-6. PubMed ID: 15193766
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.